We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects.AuthorsKomoroski B; Vachharajani N; Boulton D; Kornhauser D; Geraldes M; Li L; Pfister MPublicationClinical pharmacology and therapeutics, 2009, Vol 85, Issue 5, p520ISSN1532-6535Publication typearticleDOI10.1038/clpt.2008.251